How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma

Shares of Viking Therapeutics (VKTX) gained more than 11% on Wednesday after the company announced that it had signed a broad multi-year manufacturing agreement with CordenPharma for both the oral and subcutaneous (SC) formulations of its obesity drug.Viking Therapeutics is one of the few biotech stocks that has shown immense potential in the obesity space. It is developing VK2735, an investigational novel dual GLP-1 and GIP receptor agonist, in different clinical studies as oral and SC versions for treatin ...